Invatech and Phlo health tech companies collaborate to expand

Photo shows Adam Hunter, Lauren Nicholson and Nadeem Sarwar of Phlo
Invatech and Phlo

Two health tech firms are collaborating to continue the digital revolution in pharmacy and drive the rapid expansion in the online sector across the UK. .

Online pharmacy Phlo is currently experiencing monthly compound growth of 20 per cent, after launching in January 2020. It now serves more than 10,000 private and NHS patients and is the only pharmacy to guarantee same day delivery of medicines.

As the company targets continued expansion, it is deploying a Patient Medication Record (PMR) system called Titan, designed by Bristol health tech pioneers Invatech Health.

Their Titan Enterprise product is already in use by leading online pharmacies around the UK, offering these businesses a platform which can support their ambitious growth plans while offering customised experiences for both customers and operations teams.

As such, Titan Enterprise is expected to bring Phlo efficiency gains of 60 per cent by the end of 2022, as the business executes expansion.

Nadeem Sarwar, CEO of Phlo, said: “Our business is growing at such a rate that we need to continue to improve our systems, to ensure that the patient journey is as smooth and seamless as possible.

“In addition, like pharmacies across our sector we also need to take operational load off the shoulders of pharmacists, to free up their time.

“Titan will help us do that. For example, new patient enrolment is currently being done manually by pharmacists, who should really be dealing with patients. So with Titan, we’ll be able to onboard patients faster.

“And of course the software will help with the security and productivity of our pharmacy and operations teams, while providing better data and analytics to enable us to make informed decisions which can support our future growth.”

Earlier this year, Invatech Health announced a further £950,000 loan from Innovate UK, under a programme to support game-changing innovations in the UK’s SME community.

The loan will support ongoing development of Titan, which is the first PMR system to receive NHS accreditation for 15 years.

The entirely new, innovative, cloud-based solution can manage end-to-end workflow within pharmacies – of medicine dispensing and management, control of business activities and reporting – to speed up the user experience for patients and practice owners alike.

Crucially it aims to free up pharmacists’ time, enabling them to focus on newly-commissioned patient services designed to relieve the burden from under-pressure GPs and the wider NHS.

Tariq Muhammad, CEO of Invatech Health, said: “Having established our systems in the community pharmacy sector, we are now enjoying rolling out Titan to the online pharmacy sector. We’re processing prescriptions at a speed which is unheard of until now.

“It’s been an intense period of work between teams at both companies but we jointly recognised the opportunity and the importance of what we were doing. I’m very proud of my team for the work that they have done and the partnership we have developed with the Phlo team.

“We’re delighted to be supporting Phlo with its future growth plans, benefitting not only their business but also the services enjoyed by patients and, ultimately, the NHS as a whole.”

Backed by crowd funding of £1.65 million in the past 12 months, Phlo now has plans to expand its network of pharmacy hubs to major cities across the UK.

With headquarters in Glasgow, where operations and technology teams are based, it currently operates pharmacy centres in London and Birmingham, where it launched earlier this month.

Nadeem Sarwar, CEO of Phlo, added:“It’s great to be part of a collaboration between two young, innovative healthcare companies who are looking to help transform the way that people control and access their medication, facilitating that move into the digital pharmacy space.

“We know that only one per cent of prescription patients are currently receiving pharmacy services online, so there’s a massive opportunity there. And as the pandemic accelerates the trend for digital services, we know that our model is only going to increase in viability.

“Titan is going to help us properly scale up. It will make a huge difference to the way we operate, and also to our patient care which is our absolute north star of how we operate.”